Most Popular Angioplasty Web Site
Expert Insights & Feature Articles
Evolut™ PRO+ TAVI System
TAVI Evolut Pro+ System Receives CE Mark in Europe
The system includes 4 valve sizes with an external pericardial tissue wrap that provides advanced sealing for the largest annular range (for self-expanding TAVI technology) on the market. The approval follows a recent indication expansion for the Evolut platform in Europe for patients with severe aortic stenosis who are at a low risk of surgical mortality and patients with bicuspid aortic valves who are at intermediate, high and extreme risk of surgical mortality.
Harmony™ Transcatheter Pulmonary Valve (TPV)
Transcatheter Harmony Pulmonary Valve Gets OK from FDA
The Harmony is the 1st minimally invasive therapy created to treat patients with a specific type of congenital heart defect of the right ventricle, one of the four chambers of the heart, which makes it difficult for blood to travel from the heart to the lungs.
Shockwave's Intravascular Lithotripsy System
FDA Grants Approval to Shockwave Intravascular Lithotripsy for Use in the Coronary Arteries
This innovative technology, which was granted Breakthrough Device designation by the FDA, is now available in the United States to treat problematic calcium in the coronary arteries, which can reduce blood flow in the heart.
Dr. Charles Dotter
Charles Dotter Invents Angioplasty
Angioplasty was born 57 years ago on January 16, 1964 when Dr. Charles T. Dotter, a radiologist in Portland, Oregon, performed the first angioplasty. But it wasn’t in the heart; it was in the leg, and it saved an 82-year-old woman from having an amputatation.
Boston Scientific's Lotus™ Valve for TAVR
Boston Scientific Withdraws Lotus Edge™ from Market
Originally designed as a unique aortic valve system that could be repositioned and retrieved, the Lotus™ Valve System is now also recalled. On Tuesday, Boston Scientific announced "global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system."
Medtronic's Resolute Onyx Drug-Eluting Stent
Medtronic's Resolute Onyx™ Drug Eluting Stent (DES) First to Receive 1-Month DAPT Labeling in the U.S.
The U.S. FDA has approved an expanded indication for only one-month of dual-antiplatelet therapy (DAPT - the combination of aspirin and an anti-clotting medication) in high bleeding risk (HBR) patients implanted with the Resolute Onyx™ DES. It's the first-and-only DES in the U.S. that is approved for this indication.
Puritan Bennett™ 980 ventilator by Medtronic
*COVID-19* Cardiac Arrest Deaths at Home in NYC Have Increased By a Startling 800%
There's been a 50% or more drop in the number of people receiving emergency treatment for heart attacks in many hospitals. Physicians have been speculating why this might be. Now frightening numbers from New York City's overwhelmed emergency medical system may provide part of the answer: hundreds of people a day have been dying of cardiac arrest in their homes, an eight-fold increase over the same period last year.
Twitter poll showing significant drop in patients presenting with heart attack symptoms (MI/ACS)
*COVID-19* Doctors Say: Don't Sit Out a Heart Attack at Home
Since the onset of the novel coronavirus COVID-19, hospital emergency departments have seen a precipitous drop in the number of heart attack patients presenting for treatment. Not getting treated means heart muscle dies. What should patients do?
Dr. Patel during a telerobotic procedure
Interview with Tejas Patel & Samir Pancholy
In December 2018, Dr. Tejas Patel performed the world's first teleroboticU coronary angioplasty. Stationed 32km from the hospital and the patients, he did five PCI procedures, all successful. In this interview Dr. Patel and his colleague, Dr. Samir Pancholy, discuss telerobotic PCI.
Hirotoshi Watanabe, MD
STOPDAPT-2: Is a Month of DAPT Plus a Year of Clopidogrel Safe and Effective?
Dr. Hirotoshi Watanabe discusses his team's recent study, published in the Journal of the American Medical Association, which demonstrated that 1 month of DAPT followed by clopidogrel monotherapy, compared with 12 months of DAPT with aspirin and clopidogrel, resulted in a significantly lower rate of a composite of cardiovascular and bleeding events, meeting criteria for both noninferiority and superiority. (posted in collaboration with TCROSS NEWS)
Medtronic Resolute Onyx Zotarolimus-Eluting Stent
FDA Approves Resolute DES for Use in Chronic Total Occlusions
The FDA today approved an expanded indication for Medtronic's family of Resolute zotarolimus-eluting coronary stents: use in the treatment of de novo chronic total occlusions (CTO). This approval includes all Resolute DES devices, including the Resolute Onyx™ and Resolute Integrity™ DES.
The First EVAR
The field of endovascular repair and intervention has grown exponentially since the 1st endovascular repair of an abdominal aortic aneurysm (EVAR) was performed by Dr. Juan Parodi in 1990 in Buenos Aires. It took a while to be accepted, but today the endovascular approach is the preferred procedure to repair an AAA. This is due to the advances in medical device design and the dedication of physicians to this less invasive non-surgical approach.
5-Year Data for IN.PACT Drug-Coated Balloon in SFA Show Improved Outcomes Over Standard PTA
The IN.PACT Admiral DCB bested standard percutaneous transluminal angioplasty (PTA) for repeat interventions with almost 75% of the IN.PACT cohort of patients free from re-intervention through five-years. As for safety, there were no device or procedure-related deaths in either the DCB or PTA groups at five-years.
stent expansion chart
Drug-Eluting Stent Expansion Chart
A useful chart for the cath lab wall, this chart, created by Dr. Ajay Kirtane and the teams at NY Presbyterian/University of Columbia Medical Center, shows the nominal and post-dilatation expansion limits for four widely-used drug-eluting stents: Synergy (Boston Scientific), Resolute Onyx (Medtronic), Xience Sierra (Abbott Vascular), and EluNIR (Medinol/Cordis).
Dr. Noriaki Moriyama
Neoatherosclerosis Five Years After BVS Implantation
Dr. Noriaki Moriyama discusses the recent study, published in the Journal of the American College of Cardiology, which showed outcomes observed at five years after implantation with the Absorb Bioresorbable Vascular Scaffold (posted in collaboration with TCROSS NEWS)
Absorb BVS
Study: Similar Outcomes for 6 vs. 12 Months of DAPT for STEMI Patients Treated with Resolute Integrity DES
One year is the recommended DAPT duration for STEMI patients after stenting. But this new study shows that 6 months may be adequate with certain devices: important data, especially for patient at high risk for bleeding.
Intrepid transcatheter mitral valve replacement (TMVR)
Medtronic's Intrepid™ Transcatheter Mitral Valve Replacement (TMVR) System
The Intrepid TMVR system integrates self-expanding, dual-stent technology with a tissue valve to facilitate catheter-based implantation without the need for open-heart surgery. The Intrepid is compressed inside a hollow delivery catheter and is inserted between the ribs to enter the heart. The new replacement valve is expanded directly into the malfunctioning mitral valve.
Interventional Cardiologist Dr. Sanjay Patel
"The Whole Story is About Increasing Patient Happiness."
Interview with Dr. Ferdinand Kiemeneij
In this two-part 20th anniversary interview, the "father of transradial intervention, " talks about the history and future of TRI.

Angioplasty News

RSS Angioplasty News Feed Get our RSS News Feed
Medtronic's Evolut Pro+ TAVI System Gets CE Mark (May 3)
Harmony Transcatheter Pulmonary Valve Gets FDA OK (Mar 26)
FDA OKs Shockwave's Intravascular Lithotripsy for the Coronaries (Feb 16)
Boston Scientific Withdraws Lotus Edge™ from Market (Nov 20)
The Resolute Onyx DES from Medtronic Receives FDA OK for 1-Month of DAPT in High-Bleeding Risk Patients (Oct 1)
Medtronic Abre Self-Expanding Venous Stent Demonstrates Favorable Outcomes in Patients (Jun 16)
Shockwave Medical: CMS Has Created New Codes for Intravascular Lithotripsy (Jun 8)
Dr. Jeffrey Popma Joining Medtronic as VP and CMO of Coronary, RDN, and Structural Heart (May 18)
Cardiac Arrest Deaths at Home in NYC Have Increased By a Startling 800% (Apr 8)
Doctors Say: Don't Sit Out Your Heart Attack at Home (Apr 6)
Pivotal Study for Shockwave's Intravascular Lithotripsy Completes Enrollment (Apr 6)
Philips Increases Ventilator Production (Mar 22)
Medtronic Ramps UpProduction of Ventilators (Mar 19)
Medtronic Begins New SPYRAL Pilot Study for RDN (Feb 4)
Interview with Tejas Patel and Samir Pancholy on Telerobotic PCI (Sep 23)
FDA OK to Medtronic's Next-Gen Evolut™ PRO+ (Sep 23)
IN.PACT AV Access Trial Meets Primary Safety and Effectiveness Endpoints (Sep 7)
FDA Fast Tracks Shockwave IVL Device Review (Sep 3)
FDA Approves SAPIEN3 TAVR for Low Risk Patients (Aug 16)
FDA Approves CoreValve Evolut TAVR for Low Risk Patients (Aug 16)
Siemens to Acquire Corindus Vascular Robotics (Aug 8)
Dr. Watanabe Discusses the Results of the STOPDAPT-2 RCT (Jul 25)
Philips Launches IntraSight Platform, integrating physiology, imaging and co-registration tools (May 20)
Bringing Japanese Know-How to the Global Market: A Visit to Shimadzu Medical Systems (Apr 24)
FDA OK to Resolute DES for Use in Chronic Total Occlusions (Feb 26)
Medtronic Valiant™ Captivia™ Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients (Jan 30)
Philips Launches Azurion with FlexArm (Jan 17)
Medtronic Launches Mobile App for Smartphone-Connected Pacemakers (Jan 15)
Abiomed Invests $15M in Shockwave (Dec 11)
In Honor of #VEITH2018: The First EVAR (Nov 13)
Low Profile Valiant Navion Thoracic Stent System Garners CE Mark in Addition to FDA Approval (Nov 13)
VIVA: 5-Yr Data for IN.PACT DCB Show Superiority over PTA (Nov 12)
FDA Approval for Valiant Navion™ Thoracic Stent Graft System (Oct 23)
New Data for IN.PACT DCB Show Superiority/Durability over PTA (Oct 2)
Medtronic: 5-yr Outcomes for CoreValve; 2-yr Outcomes for SURTAVI (Sep 24)
FDA Oks IN.PACT DCB Lengths of 200mm & 250mm (Jun 23)
Resolute Onyx 1-Month OCT Study: 92.3% Stent Coverage (May 24)
FDA Oks Abbott's Xience Sierra Everolimus-Eluting Stent (May 23)
Shockwave Launches Coronary Lithotripsy System in Europe (May 21)
Dr. Moriyama Discusses Study of BVS at Five Years (May 8)
IN.PACT DCB Approved for Long Lesions Up To 360mm (Apr 23)
FDA Approves Medtronic's 2.0mm Resolute Onyx (Feb 26)
IN.PACT 2-Year Data Presented at LINC 2018 (Jan 30)
200 Patient Study: Abre Venous Self-Expanding Stent System in Patients with Deep Venous Disease (Jan 24)
Medtronic: ENCHANT Study to Assess ChEVAR Parallel Graft Technique with Endurant II/IIs (Jan 24)
3-year Outcomes of Surgical vs. Endovascular Revasculization for CLI Patients (Jan 10)
Outcomes after STEMI DES Same for 6 vs 12 Months of DAPT (Jan 8)
Dr. Yoshikawa discusses the DAPT Score in a Japanese Cohort (Nov 10)
6-Month Data for Evolut PRO TAVR Presented at TCT (Nov 2)
Is TMVR the New TAVR? Transcatheter Mitral Valve Replacement (Nov 1)
VIDEO: Complex CTO-PCI: The Japanese Approach with Dr. Etsuo Tsuchikane (Oct 31)
Medtronic's Evolut PRO Now Available in Europe (Jul 31)
Abbott Study: Is 3 Months of DAPT After XIENCE OK? (Jul 25)
FDA OK to CoreValve TAVR for Intermediate Risk Patients (Jul 10)
Dr. Shun Kohsaka: half the STEMI cases in Japan have a DTB time of > 90 min. (Jun 30)
Dr. Osamu Iida discusses the PRIORITY registry and if there is benefit for revascularization in poor-risk CLI patients (Jun 19)
FDA Approves Medtronic's Resolute Onyx DES (May 1)
History, Gruentzig, and Abbott’s Absorb “Dissolving Stent” (Apr 6)
UPDATED: Abbott's Absorb BVS in Europe Will Only Be Available to Approved Registry Sites (Apr 6)
FDA OK to Medtronic's Next-Gen CoreValve TAVR (Mar 22)
Visit current news, and news archives

Burt Cohen, Editor of Angioplasty.Org
"Voice in the Ear": Editor Burt Cohen's stent and device blog.

Recent Posts:

The Activated Patient
"The Activated Patient": Patient info and empowerment blog
Patients Are Talking About...
  • I had radial angiography 2 days was a fascinating experience and was able to watch part of the procedure. I feel fantastic, have no "heart ache" or any problems with my arm.
  • I can't afford my post-stenting meds, where can I find help paying for Plavix or Effient?
  • I'm 64. After 4 stents and 2 heart attacks since Dec. 2008, I'm as physically active or more so than ever. I plan to hit 4,000 miles on my bike this year. I've hiked/climbed at 13,000 feet.
Patients Are Reading About...
5 Crucial Questions To Ask Your Doctor About New Heart Disease Treatments
Make sure you are benefiting from the most up-to-date research, and have access to the treatments that best fit your needs and preferences.
   Doctor and Patient
Radial Hospital Locator
A list of physicians and hospitals offering the transradial (wrist) approach to angiograms, angioplasty and stent procedures.
  Transradial Hospital
Read patient stories and Learn about medications after stenting, symptoms and complications, care giving, taking charge of your health, communicating with your cardiologist and much more in our Patient Center.
Angioplasty Inventor, Dr. Andreas Gruentzig
see video clip:
" The 1st Angioplasty"
ANGIOPLASTY AT 40: 2017 marked the 40th anniversary of coronary angioplasty. In 1977 in Zurich, Switzerland, a young physician named Andreas Gruentzig inserted a catheter into a patient's coronary artery and inflated a tiny balloon, successfully opening a blockage and restoring blood flow to a human heart.
Today over two million coronary angioplasties are performed worldwide each year and angioplasty has become the gold standard for emergency heart attack treament.
(View videos, interviews, and photos in our Angioplasty History Center, or order our DVD, "PTCA: A History.") Angioplasty History DVD
What People Are Saying About Angioplasty.Org:
"Everyone, please consider donating to this site, it is a wealth of information and comfort. Where else can you get such great information AND expedited? My dr's don't return phone calls as quickly as I've gotten responses here!" -- Denise, Connecticut, USA
"Angioplasty.Org is awesome; I always refer patients to it. It makes a difference big time. They go and they look and see all the people interviewed and these well-known cardiologists around the world talking about it, and it takes that anxiety away." -- Sanjay Patel, MD, Houston, Texas, USA
"Thanks to Angioplasty.Org for all the info which helped a lot in my decision making and post procedure recovery." -- Muralidharan, Chennai, India
"Burt Cohen (Senior Editor of Angioplasty.Org) has been documentarian of this field of medicine for 30 years" -- Dr. Stephen Oesterle, SVP Medicine and Technology, Medtronic Corp.
"I just want you to know that you probably saved [my husband's] life by telling your story, and I want to thank you for it." -- Marie, Canada
Like your local educational TV or radio station, Angioplasty.Org relies on help from visitors like you. The grant funding we receive does not fully cover our costs; please consider making a recurring monthly contribution or a one-time donation.
Thank You to Our Industry Grantmakers:
Medtronic, Inc.
Volcano Corporation
Toshiba America
Medical Systems
Cardium Therapeutics
Lenox Hill Heart and Vascular Institute of NY
Freddie Award for International Health and Medical Media
Britannica Selection
Selected as an "Internet iGuide" by Encyclopedia Brittanica
    Health On the Net

send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2021